Basic information Safety Supplier Related

11-Dideuterolinoleic acid

Basic information Safety Supplier Related

11-Dideuterolinoleic acid Basic information

Product Name:
11-Dideuterolinoleic acid
Synonyms:
  • 11-Dideuterolinoleic acid
  • Balixafortide (POL6326
  • POL-6326)
  • Cyclo[L-alanyl-L-cysteinyl-L-seryl-L-alanyl-D-prolyl-(2S)-2,4-diaminobutanoyl-L-arginyl-L-tyrosyl-L-cysteinyl-L-tyrosyl-L-glutaminyl-L-lysyl-D-prolyl-L-prolyl-L-tyrosyl-L-histidyl], cyclic (2→9)-disulfide
  • Balixafortide TFA salt
  • Balixafortide(POL6326) (free base)
  • POL6326 (Balixafortide) TFA salt
CAS:
1051366-32-5
MF:
C84H118N24O21S2
MW:
1864.11
Mol File:
1051366-32-5.mol
More
Less

11-Dideuterolinoleic acid Chemical Properties

Density 
1.58±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:100.0(Max Conc. mg/mL);45.33(Max Conc. mM)
Water:100.0(Max Conc. mg/mL);45.33(Max Conc. mM)
pka
9.89±0.15(Predicted)
Water Solubility 
Water: 100 mg/mL (53.64 mM);
Sequence
H-Ala-Cys-Ser-Ala-Pro-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro-Tyr-His-OH(Disulfide bridges Cys-Cys)
More
Less

11-Dideuterolinoleic acid Usage And Synthesis

Uses

Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2].

in vivo

Balixafortide is optimized for favorable mouse absorption, distribution, metabolism and excretion (ADME) properties with balanced plasma protein binding, greater plasma and microsomal stability[1].

IC 50

CXCR4: <10 nM (IC50)

References

[1] Zimmermann J, et al. Anti-tumor cell activity and in vitro profile of the next generation CXCR4 antagonist Balixafortide. Ann Oncol. 2018 Oct;29 Suppl 8:viii103.
[2] Karpova D, et al. Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial. J Transl Med. 2017 Jan 3;15(1):2. DOI:10.1186/s12967-016-1107-2

11-Dideuterolinoleic acidSupplier

ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
010-50973130 18101056239
Email
3193328036@qq.com
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471
Email
sales@sarms4muscle.com